Testosterone therapy in men with classical versus functional hypogonadism: results from a controlled 9 ‐years, real‐world registry study

Discussion and conclusionThe therapeutic outcomes of TTh across distinct hypogonadal populations demonstrate heterogeneous responses, significantly influenced by diagnostic categorization, age, and baseline risk factor profiles.

Source: Andrology - March 16, 2024 Category: Urology & Nephrology Authors: Michael Zitzmann, Jann ‐Frederik Cremers, Claudia Krallmann, Armin Soave, Sabine Kliesch Tags: ORIGINAL ARTICLE Source Type: research